My wife is pretty healthy and got the AZ 1 week ago and is still getting headaches. Her Dr. said she should be okay, we are taking her blood pressure 4 times a day. The Dr says if they don't stop by the end of this week to go to the hospital. We are not waiting that long, I am taking her to the hospital as soon as I get home. She absolutely refuses to get a second dose of it.
Maybe we should get more info before we allow them to put this stuff into our bodies.
It’s time to halt AstraZeneca shots in Canada, except for people 40 or older in hotspots, says Andrew Morris, a doctor on Ontario’s COVID-19 science advisory…
Ontario’s COVID science table, in a brief published Friday, said the risk, based on published estimates, could be as much as one in 26,000.
Morris’ best estimate is that one in 40,000 doses will lead to VITT, a condition that frequently results in complications, with about one in five leading to death and many more cases of severe illness. Given the risk, AstraZeneca only makes sense for those at very high risk of COVID, he said. “But why give them AZ, when we can give them an mRNA vax?”
CDC reports 28 cases of rare blood clotting among 8.7 million people given Johnson & Johnson vaccine
From CNN's Maggie Fox
The US Centers for Disease Control and Prevention has reports of 28 people who have developed a rare blood clotting syndrome after being given the Johnson & Johnson coronavirus vaccine.
Three people have died, with no additional deaths since the last update in April, the CDC’s Dr. Tom Shimabukuro told a meeting of CDC vaccine advisers Wednesday. He said 8.7 million people have been given the Janssen vaccine.
The CDC has said the condition, thrombosis with thrombocytopenia syndrome (TTS), is plausibly linked to J&J’s Janssen vaccine, but has said the benefits of the vaccine nonetheless outweigh the risk. All cases have been seen in people ages 18 to 59. “Most of the these TTS cases are occurring in the 30-49 year-old age group,” Shimabukuro said.
While most cases were among women, six cases were reported among men, Shimabukuro told the CDC’s Advisory Committee on Immunization Practices. He said 19 had a type of brain blood clot called thrombosis of the cerebral venous sinus, or CVST, while others had different types of blood clots.
The CDC has alerted doctors and the patients about the possibility of the complication so it can be recognized and treated promptly and properly.
“There were no cases with a known or documented coagulation disorder,” Shimabukuro said. That indicates it’s difficult to predict who might develop the condition.
“It is important to recognize TTS early and initiate appropriate treatment,” he added. “TTS is a rare, clinically serious and life-threatening condition.”